tetano
Editor, Senior Moderator
Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Mar 4;48(0):E007. doi: 10.3760/cma.j.cn112148-20200218-00093. [Epub ahead of print] [h=1][Comparison of heart failure and 2019 novel coronavirus pneumonia in chest CT features and clinical characteristics].[/h]
[Article in Chinese; Abstract available in Chinese from the publisher]
Zhu ZW[SUP]1[/SUP], Tang JJ[SUP]1[/SUP], Chai XP[SUP]2[/SUP], Fang ZF[SUP]1[/SUP], Liu QM[SUP]1[/SUP], Hu XQ[SUP]1[/SUP], Xu DY[SUP]1[/SUP], Tang L[SUP]1[/SUP], Tai S[SUP]1[/SUP], Wu YZ[SUP]2[/SUP], Zhou SH[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] in English, Chinese
Objective: To identify the characteristics including clinical features and pulmonary computed tomography (CT) features of heart failure and novel coronavirus pneumonia(COVID-19). Methods: This study was a retrospective study. A total of 7 patients with Heart failure and 12 patients with COVID-19 in the Second Xiangya Hospital of Central South University between December 1, 2019 and February 15, 2020 were enrolled. The baseline clinical and imaging features of the two groups were statistically analyzed. Results: There was no significant difference in age and sex between the two groups, but the incidence of epidemiological contact history, fever or respiratory symptoms in the COVID-19 group was significantly higher than that in the heart failure group (12/12 vs. 2/7, P=0.001; 12/12 vs. 4/7, P<0.001). While the proportion of cardiovascular diseases and impaired cardiac function was significantly less than that of the heart failure group(2/12 vs.7/7, P<0.001; 0/12 vs.7/7, P<0.001). For imaging features, both groups had ground-glass opacity and thickening of interlobular septum, but the ratio of central and gradient distribution was higher in patients with heart failure than that in patients with COVID-19 (4/7 vs. 1/12, P=0.04). In heart failure group, the ratio of the expansion of small pulmonary veins was also higher (3/7 vs. 0, P=0.013), and the lung lesions can be significantly improved after effective anti-heart failure treatment. Besides, there are more disease with rounded morphology in COVID-19 (9/12 vs. 2/7, P=0.048) . Conclusions: More patients with COVID-19 have epidemiological history and fever or respiratory symptoms. There are significant differences in chest CT features, such as enlargement of pulmonary veins, lesions distribution and morphology between heart failure and COVID-19.
[h=4]KEYWORDS:[/h] COVID-19; Heart failure; Pulmonary computed tomography
PMID: 32129583 DOI: 10.3760/cma.j.cn112148-20200218-00093
[Article in Chinese; Abstract available in Chinese from the publisher]
Zhu ZW[SUP]1[/SUP], Tang JJ[SUP]1[/SUP], Chai XP[SUP]2[/SUP], Fang ZF[SUP]1[/SUP], Liu QM[SUP]1[/SUP], Hu XQ[SUP]1[/SUP], Xu DY[SUP]1[/SUP], Tang L[SUP]1[/SUP], Tai S[SUP]1[/SUP], Wu YZ[SUP]2[/SUP], Zhou SH[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] in English, Chinese
Objective: To identify the characteristics including clinical features and pulmonary computed tomography (CT) features of heart failure and novel coronavirus pneumonia(COVID-19). Methods: This study was a retrospective study. A total of 7 patients with Heart failure and 12 patients with COVID-19 in the Second Xiangya Hospital of Central South University between December 1, 2019 and February 15, 2020 were enrolled. The baseline clinical and imaging features of the two groups were statistically analyzed. Results: There was no significant difference in age and sex between the two groups, but the incidence of epidemiological contact history, fever or respiratory symptoms in the COVID-19 group was significantly higher than that in the heart failure group (12/12 vs. 2/7, P=0.001; 12/12 vs. 4/7, P<0.001). While the proportion of cardiovascular diseases and impaired cardiac function was significantly less than that of the heart failure group(2/12 vs.7/7, P<0.001; 0/12 vs.7/7, P<0.001). For imaging features, both groups had ground-glass opacity and thickening of interlobular septum, but the ratio of central and gradient distribution was higher in patients with heart failure than that in patients with COVID-19 (4/7 vs. 1/12, P=0.04). In heart failure group, the ratio of the expansion of small pulmonary veins was also higher (3/7 vs. 0, P=0.013), and the lung lesions can be significantly improved after effective anti-heart failure treatment. Besides, there are more disease with rounded morphology in COVID-19 (9/12 vs. 2/7, P=0.048) . Conclusions: More patients with COVID-19 have epidemiological history and fever or respiratory symptoms. There are significant differences in chest CT features, such as enlargement of pulmonary veins, lesions distribution and morphology between heart failure and COVID-19.
[h=4]KEYWORDS:[/h] COVID-19; Heart failure; Pulmonary computed tomography
PMID: 32129583 DOI: 10.3760/cma.j.cn112148-20200218-00093